Jeff Cislini
CIK: 0001969082
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Revolution Medicines, Inc.
Discretionary Trading P&L
Holdings
Transaction History (36 total)
- Sep 25, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct765 shares at avg. $207.32$159K - Sep 16, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct52 shares at avg. $195.01$10K - Sep 16, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct3.3K shares at avg. $199.30$660K - Aug 21, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct3.4K shares at avg. $207.24$705K - Aug 21, 2026RVMD
Revolution Medicines, Inc.
Exercise(M)Direct29.7K shares at avg. $18.56$551K - Aug 21, 2026RVMD
Revolution Medicines, Inc.
Exercise(M)Direct26.6K shares at avg. $21.61$575K - Aug 21, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct17.3K shares at avg. $208.37$3.6M - Aug 21, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct25.8K shares at avg. $209.25$5.4M - Aug 21, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct2.5K shares at avg. $210.26$534K - Aug 21, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct4.5K shares at avg. $211.34$951K - Aug 21, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct3.3K shares at avg. $212.06$703K - Jun 16, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct2.2K shares at avg. $156.12$337K - Mar 19, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct1.2K shares at avg. $97.44$113K - Mar 17, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct1.8K shares at avg. $99.48$179K - Mar 1, 2026RVMD
Revolution Medicines, Inc.
Award(A)Direct14.5K shares- - Jan 21, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct908 shares at avg. $115.60$105K - Dec 16, 2025RVMD
Revolution Medicines, Inc.
Sale(S)Direct2.7K shares at avg. $76.82$206K - Nov 18, 2025RVMD
Revolution Medicines, Inc.
Exercise(M)Direct13.4K shares at avg. $42.45$568K - Nov 18, 2025RVMD
Revolution Medicines, Inc.
Sale(S)Direct13.4K shares at avg. $70.14$939K - Oct 17, 2025RVMD
Revolution Medicines, Inc.
Sale(S)Direct12K shares at avg. $55.00$660K - Oct 17, 2025RVMD
Revolution Medicines, Inc.
Exercise(M)Direct12K shares at avg. $36.57$439K - Sep 24, 2025RVMD
Revolution Medicines, Inc.
Sale(S)Direct1.8K shares at avg. $44.26$80K - Sep 16, 2025RVMD
Revolution Medicines, Inc.
Sale(S)Direct1.9K shares at avg. $45.82$86K - Jun 20, 2025RVMD
Revolution Medicines, Inc.
Sale(S)Direct1.9K shares at avg. $39.61$76K - Jun 16, 2025RVMD
Revolution Medicines, Inc.
Sale(S)Direct1.9K shares at avg. $39.83$75K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 25, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 765 | $207.32 | $158,600 | Direct |
| Sep 16, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 52 | $195.01 | $10,140 | Direct |
| Sep 16, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 3,314 | $199.30 | $660,491 | Direct |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 3,400 | $207.24 | $704,603 | Direct |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | Exercise(M) | 29,680 | $18.56 | $550,861 | Direct |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | Exercise(M) | 26,600 | $21.61 | $574,826 | Direct |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 17,323 | $208.37 | $3,609,573 | Direct |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 25,817 | $209.25 | $5,402,200 | Direct |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 2,540 | $210.26 | $534,072 | Direct |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 4,500 | $211.34 | $951,038 | Direct |
| Aug 21, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 3,314 | $212.06 | $702,761 | Direct |
| Jun 16, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 2,157 | $156.12 | $336,749 | Direct |
| Mar 19, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 1,163 | $97.44 | $113,323 | Direct |
| Mar 17, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 1,795 | $99.48 | $178,567 | Direct |
| Mar 1, 2026 | RVMD Revolution Medicines, Inc. | Award(A) | 14,500 | - | $0 | Direct |
| Jan 21, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 908 | $115.60 | $104,965 | Direct |
| Dec 16, 2025 | RVMD Revolution Medicines, Inc. | Sale(S) | 2,688 | $76.82 | $206,484 | Direct |
| Nov 18, 2025 | RVMD Revolution Medicines, Inc. | Exercise(M) | 13,388 | $42.45 | $568,321 | Direct |
| Nov 18, 2025 | RVMD Revolution Medicines, Inc. | Sale(S) | 13,388 | $70.14 | $939,008 | Direct |
| Oct 17, 2025 | RVMD Revolution Medicines, Inc. | Sale(S) | 12,000 | $55.00 | $660,000 | Direct |
| Oct 17, 2025 | RVMD Revolution Medicines, Inc. | Exercise(M) | 12,000 | $36.57 | $438,840 | Direct |
| Sep 24, 2025 | RVMD Revolution Medicines, Inc. | Sale(S) | 1,799 | $44.26 | $79,624 | Direct |
| Sep 16, 2025 | RVMD Revolution Medicines, Inc. | Sale(S) | 1,869 | $45.82 | $85,647 | Direct |
| Jun 20, 2025 | RVMD Revolution Medicines, Inc. | Sale(S) | 1,912 | $39.61 | $75,736 | Direct |
| Jun 16, 2025 | RVMD Revolution Medicines, Inc. | Sale(S) | 1,878 | $39.83 | $74,801 | Direct |
1-25 of 36 transactions
About Cislini Jeff
Cislini Jeff (SEC CIK 0001969082) files insider reports with the SEC as SVP & General Counsel of Revolution Medicines, Inc. (RVMD).
Signal8 holds 23 ownership filings by Cislini Jeff, all Form 4s, filed between Sep 18, 2024 and Sep 29, 2026. Those filings report 36 transactions, from Sep 16, 2024 to Sep 25, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Cislini Jeff's filings is in REDWOOD CITY, CA.
Recent filings by Cislini Jeff
- Sep 25, 2026: Open-market sale of RVMD shares (Form 4, code S).
- Sep 16, 2026: Open-market sales of RVMD shares (2 lines, Form 4, code S).
- Aug 21, 2026: Open-market sale of RVMD shares (Form 4, code S).
- Aug 21, 2026: Option exercises of RVMD shares (2 lines, Form 4, code M).
- Aug 21, 2026: Open-market sales of RVMD shares (5 lines, Form 4, code S).
Other insiders filing for Revolution Medicines, Inc. (RVMD)
- Mancini Anthony
- Sandler Alan B., Chief Development Officer
- ANDERSON ELIZABETH M, Director
- Kelsey Stephen Michael
- Horn Margaret A, Chief Operating Officer
- GOLDSMITH MARK A